153 related articles for article (PubMed ID: 1480770)
1. Clinical implications of heterogeneity of tumor response to radiation therapy.
Suit H; Skates S; Taghian A; Okunieff P; Efird JT
Radiother Oncol; 1992 Dec; 25(4):251-60. PubMed ID: 1480770
[TBL] [Abstract][Full Text] [Related]
2. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system.
Stuschke M; Budach V; Stüben G; Streffer C; Sack H
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):395-408. PubMed ID: 7751182
[TBL] [Abstract][Full Text] [Related]
4. Clinical interest in determinations of cellular radiation sensitivity.
Suit HD; Baumann M; Skates S; Convery K
Int J Radiat Biol; 1989 Nov; 56(5):725-37. PubMed ID: 2573670
[TBL] [Abstract][Full Text] [Related]
5. Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers.
Roberts SA; Hendry JH
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1247-57. PubMed ID: 10613320
[TBL] [Abstract][Full Text] [Related]
6. Can modest escalations of dose be detected as increased tumor control?
Thames HD; Schultheiss TE; Hendry JH; Tucker SL; Dubray BM; Brock WA
Int J Radiat Oncol Biol Phys; 1992; 22(2):241-6. PubMed ID: 1531477
[TBL] [Abstract][Full Text] [Related]
7. The effect of heterogeneity in tumor cell kinetics on radiation dose-response. An exploratory investigation of a plateau effect.
Suwinski R; Taylor JM; Withers HR
Radiother Oncol; 1999 Jan; 50(1):57-66. PubMed ID: 10225558
[TBL] [Abstract][Full Text] [Related]
8. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
Yaromina A; Hölscher T; Eicheler W; Rosner A; Krause M; Hessel F; Petersen C; Thames HD; Baumann M; Zips D
Radiother Oncol; 2005 Aug; 76(2):206-12. PubMed ID: 16024121
[TBL] [Abstract][Full Text] [Related]
9. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing.
Bentzen SM
Radiother Oncol; 1997 May; 43(2):121-31. PubMed ID: 9192956
[TBL] [Abstract][Full Text] [Related]
10. Inter-tumor heterogeneity and radiation dose-control curves.
Zagars GK; Schultheiss TE; Peters LJ
Radiother Oncol; 1987 Apr; 8(4):353-61. PubMed ID: 3588999
[TBL] [Abstract][Full Text] [Related]
11. Half brain irradiation in a murine model of breast cancer brain metastasis: magnetic resonance imaging and histological assessments of dose-response.
Zarghami N; Murrell DH; Jensen MD; Dick FA; Chambers AF; Foster PJ; Wong E
Radiat Oncol; 2018 Jun; 13(1):104. PubMed ID: 29859114
[TBL] [Abstract][Full Text] [Related]
12. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters.
Ricciardelli EJ; Weymuller EA; Koh WJ; Austin-Seymour M; DeSautel MG; Laramore GE
Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):737-42. PubMed ID: 8018326
[TBL] [Abstract][Full Text] [Related]
13. Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data.
Levegrün S; Jackson A; Zelefsky MJ; Skwarchuk MW; Venkatraman ES; Schlegel W; Fuks Z; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1064-80. PubMed ID: 11704332
[TBL] [Abstract][Full Text] [Related]
14. Selective boosting of tumor subvolumes.
Tomé WA; Fowler JF
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):593-9. PubMed ID: 10974480
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity.
Davidson SE; West CM; Roberts SA; Hendry JH; Hunter RD
Radiother Oncol; 1990 Aug; 18(4):349-56. PubMed ID: 2244021
[TBL] [Abstract][Full Text] [Related]
16. Steepness of the dose-response curve as a function of volume in an experimental tumor irradiated under ambient or hypoxic conditions.
Khalil AA; Bentzen SM; Overgaard J
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):797-802. PubMed ID: 9369125
[TBL] [Abstract][Full Text] [Related]
17. Radiobiological and dosimetric analysis of daily megavoltage CT registration on adaptive radiotherapy with Helical Tomotherapy.
Mavroidis P; Su FC; Giantsoudi D; Stathakis S; Komisopoulos G; Shi C; Swanson G; Papanikolaou N
Technol Cancer Res Treat; 2011 Feb; 10(1):1-13. PubMed ID: 21214283
[TBL] [Abstract][Full Text] [Related]
18. Tumor radioresponsiveness versus fractionation sensitivity.
Thames HD; Suit HD
Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):687-91. PubMed ID: 3700173
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo γH2AX radiation sensitivity assay in prostate cancer: Inter-patient and intra-patient heterogeneity.
De-Colle C; Yaromina A; Hennenlotter J; Thames H; Mueller AC; Neumann T; Stenzl A; Scharpf M; Fend F; Ricardi U; Baumann M; Zips D; Menegakis A
Radiother Oncol; 2017 Sep; 124(3):386-394. PubMed ID: 28919005
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.
Pop LA; Millar WT; Visser AG; van der Kogel AJ
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
